Prognostic impact of chronic kidney disease and renal safety of contemporary therapies in patients with heart failure: a real-world analysis
Chronic kidney disease (CKD) is common in heart failure (HF) and is associated with adverse outcomes. However, its prognostic impact and the effects of contemporary HF therapies—including angiotensin receptor–neprilysin inhibitors (ARNI) and sodium–glucose cotransporter-2 inhibitors (SGLT2i)—on renal function rem...